{"product_id":"tesamorelin-10mg-ghrh-analogue-visceral-adiposity-metabolic-research-peptide","title":"Tesamorelin 10mg GHRH Analogue | Visceral Adiposity \u0026 Metabolic Research Peptide","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eTesamorelin 10mg\u003c\/strong\u003e \u003cem\u003eGHRH Analogue | Visceral Adiposity \u0026amp; Metabolic Research Peptide\u003c\/em\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH), structurally based on the native 44-amino acid hypothalamic peptide with a stabilising trans-3-hexenoyl modification at the N-terminus. The 10mg presentation is engineered for advanced research into endogenous GH release, visceral adipose tissue biology, and lipid metabolism.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMechanism of Interest\u003c\/strong\u003e Tesamorelin acts on pituitary GHRH receptors to stimulate the synthesis and pulsatile release of endogenous growth hormone, in turn elevating circulating IGF-1. The N-terminal modification confers enhanced enzymatic stability — extending half-life and bioavailability compared with native GHRH. Tesamorelin is unique among GHRH analogues in being one of the most extensively researched peptides specifically in the context of \u003cstrong\u003evisceral adipose tissue (VAT) reduction\u003c\/strong\u003e, hepatic lipid handling, and cardiometabolic markers.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eProduct Specifications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eProduct Name: Tesamorelin 10mg\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eCatalogue Reference: TES10-024\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eClass: GHRH Analogue (stabilised hexenoyl-modified GRF 1-44)\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eMolecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eMolecular Weight: ~5135.9 g\/mol\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003ePurity: ≥98% (HPLC verified)\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003ePresentation: Lyophilised solid\u003c\/li\u003e\n\u003cli class=\"whitespace-normal break-words pl-2\"\u003eStorage: -20°C\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Applications\u003c\/strong\u003e Tesamorelin is utilised across endocrinology, metabolic, and longevity research — particularly in studies investigating visceral fat reduction, hepatic steatosis and NAFLD models, lipid profiles, IGF-1 dynamics, cognitive markers in ageing populations, and broader GH-axis modulation. Its enhanced stability and pituitary specificity make it one of the more refined GHRH-class research peptides available.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eComparative Research Context\u003c\/strong\u003e Tesamorelin is frequently studied alongside other GHRH analogues such as CJC-1295 (with or without DAC) in comparative research models. Where CJC-1295 with DAC is investigated for its extended albumin-bound action, Tesamorelin is typically explored for its \u003cstrong\u003edefined pulsatile profile\u003c\/strong\u003e and well-characterised effects on adipose and metabolic endpoints.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eQuality \u0026amp; Handling\u003c\/strong\u003e Synthesised under controlled laboratory conditions and supplied as a lyophilised solid for maximum stability. Reconstitution with appropriate bacteriostatic solution is required prior to use in any research model. Every batch is subjected to rigorous quality control to ensure ≥98% purity, identity, and reproducibility.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eCompliance Statement\u003c\/strong\u003e All Asclepius peptide products are supplied \u003cstrong\u003estrictly for laboratory research purposes\u003c\/strong\u003e. They are not intended for human consumption, diagnosis, treatment, or therapeutic use. Enquiries relating to human application cannot be supported.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOrder with Confidence\u003c\/strong\u003e Asclepius peptides are sourced, tested, and dispatched to a clinical standard — built for researchers and practitioners who refuse to compromise on integrity, purity, or precision.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eFor technical specifications, certificates of analysis, or research support, our team is available to assist.\u003c\/p\u003e","brand":"Asclepius Peptides","offers":[{"title":"Default Title","offer_id":53453766754646,"sku":null,"price":179.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0981\/6843\/9126\/files\/rn-image_picker_lib_temp_6aa0fc12-5737-4ea0-9609-eb3405728ebb.png?v=1778053086","url":"https:\/\/asclepiuspeptides.co.uk\/products\/tesamorelin-10mg-ghrh-analogue-visceral-adiposity-metabolic-research-peptide","provider":"Asclepius Peptides","version":"1.0","type":"link"}